A detailed history of Gts Securities LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Gts Securities LLC holds 101,200 shares of DVAX stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101,200
Previous 15,515 552.27%
Holding current value
$1.14 Million
Previous $216,000 481.02%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$11.7 - $14.98 $286,813 - $367,219
24,514 Added 158.0%
40,029 $496,000
Q4 2023

Feb 14, 2024

SELL
$13.09 - $14.98 $80,791 - $92,456
-6,172 Reduced 28.46%
15,515 $216,000
Q3 2023

Nov 15, 2023

BUY
$12.64 - $14.99 $101,789 - $120,714
8,053 Added 59.07%
21,687 $320,000
Q2 2023

Aug 15, 2023

BUY
$9.85 - $13.17 $134,294 - $179,559
13,634 New
13,634 $176 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.42B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.